Direct method scaling from UHPLC to HPLC: Is this feasible for pharmaceutical methods?

American Pharmaceutical Review

Volumn 14, Issue 5, 2011, Pages 32-40

  Webster Sr , Gregory K ^a   Elliott, Ashley ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; DRUG INDUSTRY; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK ASSESSMENT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 80052604410     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. J.E. MacNair, K.C. Lewis and J.W. Jorgenson, Anal. Chem. 69 (1997) 983-989.
2. J.E. MacNair, K.D. Patel and J.W. Jorgenson, Anal. Chem 71 (1999) 700-708.
3. L. Tolley, J.W. Jorgenson, and M.A. Moseley, Anal. Chem 73 (2001) 2985-2991.
4. L. Novakova, L. Matysova, and P. Solich, Talanta 68 (2006) 908-918.
5. S.AC. Wren and P. Tchelitcheff, J. Pharm Biomed. Anal 40 (2006) 571-580.
6. S.AC. Wren and P. Tchelitcheff, J. Chromatogr A. 1119 (2006) 140-146.
7. G. Wang, Y. Hsieh, X. Cui, K.C. Cheng and W.A. Korfmacher, Rapid Commun. Mass Spectrom 20 (2006) 2215-2221.
8. L.G. Apollonio, I.R. Whittall, D.J. Pianca, J.M. Kyd and W.A. Maher, Rapid Commun. Mass Spectrom 20 (2006) 2259-2264.
9. H. Kawanishi, T. Toyo'oka, K. Ito, M. Maeda et al., J. Chromatogr A 1132 (2006) 148-156.
10. K.A. Johnson and R. Plumb, J. Pharm. Biomed. Anal 39 (2005) 805-810.
11. I. Baranowska and B. Kowalski, Water Air Soil Pollut 211, (2010) 417-425.
12. C.J Messina, E.S. Grumbach and D.M. Diehl, LCGC 25 (2007) 1042-1049.
13. I. Baranowska, A. Wilczek and J. Baranowski, Analytical Sciences 26 (2010) 755-759.
14. A. Subasranjan, C. Srinivasulu and R. Hemant, Drug Testing and Analysis 2 (2010) 107-112.
15. M. Mezcua, A. Aguera, J.L. Lliberia, and M.A. Cortes et al., J. Chromatogr. A 1109 (2006) 222-227.
16. C.C. Leandro, P. Hancock, R.J. Fussell and B.J. Keeley J. Chromatogr. A. 1103 (2006) 94-101.
17. M. Ventura, D. Guillen, I. Anaya, and F. Broto-Puig et al., Rapid Commun. Mass Spectrom 20 (2006) 3199 -3204.
18. J.M. Cunliffe and T.D. Maloney, J. Sep. Sci. 30 (2007) 3104-3109.
19. N. Wu, J.A. Lippert and M.L. Lee, J. Chromatogr. A 911 (2001) 1-12.
20. J.A. Anspach, T.D. Maloney, R.W. Brice and L.A. Colon, Anal. Chem 77 (2005) 7489-7497.
21. S.A. Wren, J. Pharm. Biomed. Anal 38 (2005) 337-343.
22. J.M. Cunliffe, S.B. Adams-Hall and T.D. Maloney, J. Sep. Sci 30 (2007) 1214-1223.
23. X.Sun and L. Wrisley, American Pharmaceutical Review, December (2009) 26-32.
24. R.E. Majors, LC-GC 29 (2011) 476-484.
25. D. Guillarme, D.T.T. Nguyen, S. Rudaz and J.L. Veuthey, Eur. J. Pharm. Sci 66 (2007) 475-482.
26. D. Guillarme, D.T.T. Nguyen, S. Rudaz, and J.L. Veuthey, Eur. J. Pharm. Biopharm 68 (2008) 430-440.
27. M.M. Dittmann, "Approaches Towards Method Compatibility Between HPLC and UHPLC Systems", Paper 1970-6, Pittsburgh Conference & Exposition on Analytical Chemistry and Applied Spectroscopy, March 2010, Orlando.
28. U.D. Neue, D. McCabe, V. Ramesh, H. Pappa and J. DeMith, Pharmacopeial Forum 35 (2009) 1622-1626.
29. G.K. Webster and C.L. Basel, LCGC 21 (2003) 286-294.